{"nct_id":"NCT01423084","title":"Safety and Immunogenicity of Novartis Meningococcal B Vaccine Formulated With OMV Manufactured at Two Different Sites, in Healthy Adolescents Aged 11-17 Years","status":"COMPLETED","status_verified_date":"2015-02","start_date":"2011-08","start_date_type":null,"primary_completion_date":"2011-12","primary_completion_date_type":"ACTUAL","completion_date":"2011-12","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}